Abstract
Many medical centers are faced with a major challenge in making an accurate diagnosis of heparin-induced thrombocytopenia (HIT) and ensuring appropriate changes in management strategy in line with guideline recommendations. We report the initial and long-term impact and challenges of institution-wide changes in the diagnosis and management of HIT in the inpatient setting at an academic medical center. We established a HIT Task Force, consisting of a multidisciplinary team of non-malignant hematologists, nursing, pharmacist, pathology, blood bank and clinical lab informatics. Changes were implemented from 2011 to 2012. In 2013, testing for PF4 and SRA decreased by 37.5 and 85%, respectively. 100% of positive PF4 received an automatic hematology consult to guide management, leading to a 78% reduction in the use of direct thrombin inhibitors. Annual audits in the subsequent years demonstrated increasing testing for HIT due to changes in the electronic ordering system. Through continuous monitoring, these shortfalls were detected and intervene early on with continued success. The implementation of a centralized hospital-wide protocol via a multidisciplinary task force that coordinates testing and treatment of patients suspected of having HIT led to a substantial reduction in PF4 and SRA testing, as well as use of DTIs, resulting in a safe and cost-effective approach for the diagnosis and treatment of HIT. Our study highlights the important of continuous monitoring to maintain the improvements made. Despite our initial success, annual re-auditing allowed for early detection of challenges, which then allowed appropriate early intervention.
References
Greinacher A (2015) Heparin-Induced Thrombocytopenia. N Engl J Med 373:1883–1884
Kelton JG, Arnold DM, Bates SM (2013) Nonheparin anticoagulants for heparin-induced thrombocytopenia. N Engl J Med 368:737–744
Lo GK, Sigouin CS, Warkentin TE (2007) What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol 82:1037–1043
Warkentin TE, Sheppard JI, Moore JC, Kelton JG (2010) The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 8:216–218
Burnett AE, Bowles H, Borrego ME, Montoya TN, Garcia DA, Mahan C (2016) Heparin-induced thrombocytopenia: reducing misdiagnosis via collaboration between an inpatient anticoagulation pharmacy service and hospital reference laboratory. J Thromb Thrombolysis 42:471–478
Hasan M, Malalur P, Agastya M et al (2016) A high-value cost conscious approach to minimize heparin induced thrombocytopenia antibody (HITAb) testing using the 4T score. J Thromb Thrombolysis 42:441–446
Ritchie BM, Sylvester KW, Reardon DP, Churchill WW, Berliner N, Connors JM (2016) Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program. J Thromb Thrombolysis 42:616–622
Wychowski MK, Ruscio CI, Kouides PA, Sham RL (2017) The scope and value of an anticoagulation stewardship program at a community teaching hospital. J Thromb Thrombolysis 43:380–386
Linkins LA, Dans AL, Moores LK et al (2012) Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e495S-e530S
Pierce W, Mazur J, Greenberg C, Mueller J, Foster J, Lazarchick J (2013) Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit. Ann Clin Lab Sci 43:429–435
Samuelson BT, Glynn E, Holmes M, White AA, Martin DB, Garcia D (2015) Use of a computer-based provider order entry (CPOE) intervention to optimize laboratory testing in patients with suspected heparin-induced thrombocytopenia. Thromb Res 136:928–931
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Lim, M.Y., Foster, J., Rourk, A. et al. Initial and long term impact of a multi-disciplinary task force in the diagnosis and management of heparin-induced thrombocytopenia. J Thromb Thrombolysis 45, 130–134 (2018). https://doi.org/10.1007/s11239-017-1592-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-017-1592-z